文献速递肿瘤 PET/CT

PET/CT与标准影像对复发性头颈鳞癌生存预测的比较

PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
PubMed 文献 · J Nucl Med · 2018-10-12

该前瞻性配对队列研究纳入110例组织学证实的复发性头颈鳞癌患者,同日行CXR/MRI、CCT/MRI和PET/CT并盲法判读。PET/CT分期较CXR/MRI或CCT/MRI显著改变肿瘤分期(均P<0.001),且PET/CT分期可显著区分局部、局部晚期或转移性疾病的生存曲线,而CXR/MRI和CCT/MRI无法区分。

要点

  • PET/CT分期较CXR/MRI或CCT/MRI显著改变复发性HNSCC的肿瘤分期(均P<0.001)。
  • PET/CT分期可显著区分局部、局部晚期或转移性疾病的生存(log-rank P<0.001)。
  • PET/CT预测癌症特异性死亡的C-index为0.72,显著高于CXR/MRI和CCT/MRI的0.55。

核心结论

  • 与标准影像策略相反,基于PET/CT的分期在复发性HNSCC中能够显著区分局部、局部晚期或转移性疾病患者的生存过程,并预测其各自的生存概率。

研究设计与样本

  • 前瞻性配对队列研究,连续纳入2013年9月至2016年3月组织学证实的复发性HNSCC患者。
  • 所有患者在同一天、活检前接受CXR/MRI、CCT/MRI和PET/CT检查。
  • 所有影像由经验丰富的核医学医师或放射科医师团队分别进行盲法判读。
  • 共纳入110例患者(90例男性,20例女性;中位年龄66岁,范围40-87岁)。

主要发现

  • PET/CT较CXR/MRI或CCT/MRI显著改变所判定的肿瘤分期(均P<0.001)。
  • PET/CT分期Kaplan-Meier分析显示局部、局部晚期或转移性疾病预后逐步恶化(log-rank P<0.001)。
  • CXR/MRI和CCT/MRI无法在生存方面区分这些组(log-rank P分别为0.18和0.58)。
  • 预测癌症特异性死亡的整体判别能力PET/CT(C-index 0.72)显著高于CXR/MRI(C-index 0.55,P=0.001)和CCT/MRI(C-index 0.55,P<0.001)。
  • 将PET/CT加入CXR/MRI或CCT/MRI均与显著正的净重分类改善相关(均P<0.001)。

关键数值与推荐

  • 复发性癌分为局部(相当于原发I-II期)、局部晚期(相当于原发III-IVB期)或转移性(相当于原发IVC期)。

临床怎么用

  • 在复发性HNSCC中,基于PET/CT的分期可显著区分局部、局部晚期或转移性疾病的生存过程并预测生存概率。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The purpose of this study was to examine whether staging with 18F-FDG PET/CT better predicts survival in patients with recurrent head and neck squamous cell carcinoma (HNSCC) than chest x-ray (CXR) plus head and neck MRI or chest CT (CCT) plus head and neck MRI. Methods: This was a prospective cohort study based on paired data. Consecutive patients with histologically verified HNSCC recurrence were enrolled from September 2013 to March 2016. All patients underwent CXR/MRI, CCT/MRI, and PET/CT on the same day and before biopsy. All imaging studies underwent masked interpretation by separate teams of experienced nuclear physicians or radiologists. Recurrent carcinomas were categorized as localized (equivalent to primary stages I-II), locally advanced (equivalent to primary stages III-IVB), or metastatic (equivalent to primary stage IVC). Discriminative abilities for each imaging strategy with respect to cancer-specific and stage-based survival were compared using Kaplan-Meier analysis, Cox proportional-hazards regression with the Harrell concordance index (C-index), and net reclassification improvement. Results: In total, 110 patients (90 men and 20 women; median age, 66 y; range, 40-87 y) were included. PET/CT significantly changed the assigned tumor stage when compared with imaging strategies based on CXR/MRI or CCT/MRI (P < 0.001 for both). Kaplan-Meier analysis of PET/CT-based staging showed progressively worsened prognosis with localized, locally advanced, or metastatic disease (log-rank test, P < 0.001), whereas CXR/MRI and CCT/MRI were unable to distinguish between these groups in terms of survival (log-rank test, P = 0.18 and P = 0.58, respectively). Overall discriminative ability in predicting cancer-specific mortality was significantly greater for PET/CT (C-index, 0.72) than for CXR/MRI (C-index, 0.55) (P = 0.001) and CCT/MRI (C-index, 0.55)(P < 0.001). The addition of PET/CT to either CXR/MRI or CCT/MRI was associated with a significantly positive net reclassification improvement (P < 0.001 for both). Conclusion: Contrary to standard imaging strategies, PET/CT-based staging in recurrent HNSCC was able to significantly discriminate among the survival courses of patients with local, locally advanced, or metastatic disease and predict their respective survival probability.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Rohde M, Nielsen AL, Pareek M, et al. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma. J Nucl Med. 2018. PMID: 30315144. doi:10.2967/jnumed.118.217976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。